Research and Markets: Pharmaceutical Reformulation Strategies – New Technologies Extend Use Beyond Lifecycle Management

DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/0fed6744/reformulation_stra)
has announced the addition of the “Reformulation
Strategies – New Technologies Extend Use Beyond Lifecycle Management”

report to their offering.

“Reformulation
Strategies – New Technologies Extend Use Beyond Lifecycle Management”

Reformulation performs a key role in the pharmaceutical industry
enabling companies to maximize their returns on investment while
broadening treatment options and improving patient experience. It’s
potential to rejuvenate RD pipelines in the future as new technologies
emerge compliment its position as a key lifecycle management strategy.

Reformulation will continue to be a much used lifecycle management
strategy, enabling companies to boost sales before patent expiry and in
ideal cases protect sales after generics enter. However in order to
achieve this companies must focus increasingly on demonstrating provable
benefits, ideally in head to head trials against the original product.
This has become necessary as increasingly cost conscious healthcare
providers promote the use of generic therapies unless clear advantages
are demonstrated.

Biologics increasing dominance of the pharmaceutical market opens new
opportunities in reformulation and will drive the sectors future
success. Opportunities to deliver less frequent dosing or more
convenient and lower cost formulations will continue to drive the
development of new technologies.

The report, Reformulation Strategies, has been written to support
companies with their strategic plans to maximize product portfolios and
thus increase revenues across the lifecycles of their products. The
insights, analysis, and support provided can be used throughout the
pharma, biotech, and generics industries.

Key Reasons to Purchase:

– Learn what drug reformulation is and why it is such a valuable
lifecycle management tool for both pharmaceutical and biotech companies

– Assess the opportunities to use reformulation to extend grow the
revenues for your product along with which types of reformulation best
fit your needs

– Understand the new technologies that are now available to use to
support your reformulation strategy

– Benefit from the analysis of multiple case studies to help support
your company’s/brand’s strategy moving forward

– Understand how reformulation can be a successful tool to reinvigorate
your company’s RD pipeline, opening up new opportunities for past
projects which were unsuccessful

Key Topics Covered:

Chapter 1: Introduction to reformulation strategies

Chapter 2: Analysis of the key drivers of reformulation in the
pharmaceutical market

Chapter 3: Focus on controlled release reformulation strategies

For more information visit http://www.researchandmarkets.com/research/0fed6744/reformulation_stra

Leave a Reply

Your email address will not be published. Required fields are marked *